TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.350
-0.100 (-6.90%)
At close: Mar 28, 2025, 4:00 PM
1.340
-0.010 (-0.74%)
Pre-market: Mar 31, 2025, 8:09 AM EDT
TScan Therapeutics Employees
As of December 31, 2024, TScan Therapeutics had 195 total employees, including 194 full-time and 1 part-time employees. The number of employees increased by 41 or 26.62% compared to the previous year.
Employees
195
Change (1Y)
41
Growth (1Y)
26.62%
Revenue / Employee
$14,441
Profits / Employee
-$653,841
Market Cap
76.40M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 195 | 41 | 26.62% |
Dec 31, 2023 | 154 | 16 | 11.59% |
Dec 31, 2022 | 138 | 33 | 31.43% |
Dec 31, 2021 | 105 | 47 | 81.03% |
Dec 31, 2020 | 58 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TCRX News
- 1 hour ago - TScan Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 days ago - TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access - GlobeNewsWire
- 23 days ago - TScan: 2 Major Milestones Of TSC-101 To Carry Tide In 2025 - Seeking Alpha
- 26 days ago - TScan Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - GlobeNewsWire
- 7 weeks ago - TScan Therapeutics: Finding Their Footing After An Eventful ASH Meeting - Seeking Alpha
- 3 months ago - TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium - GlobeNewsWire